Haider A Alidrisi
Endocrinology — University of Basrah, Iraq
Haider A Alidrisi
LeadR Profile
Endocrinology
Subspecialties: Public Health - Oncology - Biochemistry
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2016 - 2026
Number : 54
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Optimizing Type 2 Diabetes Management in Iraq: Expert Consensus on Initiation and Intensification of Insulin-Based Treatment Options. diabetes mellitus, insulin, algorithms, therapeutics, diabetes mellitus, type 2 | Diabetes Ther | 2026 | 0 |
| Quality of Life in Polycystic Ovary Syndrome after Anti-Androgen Therapy Using PCOSQOL-47 and PCOSQOL-42. quality of life, fertility, androgens, ovary, finasteride, polycystic ovary syndrome, hyperandrogenism, therapeutics, spironolactone | Endocr Metab Immune Disord Drug Targets | 2026 | 0 |
| Cystic versus non-cystic prolactinoma: clinical, hormonal, radiological, and remission outcomes in Basrah. prolactinoma, prolactin, adenoma, therapeutics, dopamine agonists, endocrine system diseases | Front Endocrinol (Lausanne) | 2025 | 0 |
| Management outcomes of prolactinoma: a retrospective study from Southern Iraq. prolactinoma, hyperprolactinemia, retrospective studies, signs and symptoms, prolactin, adenoma, therapeutics, dopamine agonists | J Med Life | 2025 | 0 |
| Prevalence of and Factors Associated With Incidental Chronic Kidney Disease in Patients Newly Diagnosed With Type 2 Diabetes Mellitus. diabetes mellitus, kidney diseases, kidney, prevalence, diabetes mellitus, type 2 | Cureus | 2025 | 1 |
Clinical Studies 2
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Combination Osilodrostat and Cabergoline in Cushing s Disease NCT07603466 — pituitary acth hypersecretion, hypertension, dehydroepiandrosterone, adrenal insufficiency, safety, serum, acetates, cabergoline, hormones, hyperandrogenism, hypokalemia, therapeutics, hydrocortisone, mineralocorticoids, adrenocorticotropic hormone, cushing syndrome | Phase 4 | Enrolling by invitation | 2026 |
| Effect of Short term Basal Insulin Initiation in Newly Diagnosed Type 2 Diabetes on 1 year Glycemic Control NCT06107153 — diabetes mellitus, insulin glargine, fasting, blood glucose, insulin, blood, pioglitazone, metformin, glycemic control, diabetes mellitus, type 2 | N/A | Recruiting | 2023 |
LeadR Networks
Main global connection map